These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26317866)

  • 1. Longitudinal Metabolomics Profiling of Parkinson's Disease-Related α-Synuclein A53T Transgenic Mice.
    Chen X; Xie C; Sun L; Ding J; Cai H
    PLoS One; 2015; 10(8):e0136612. PubMed ID: 26317866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
    Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
    Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice.
    Wu Q; Yang X; Zhang Y; Zhang L; Feng L
    Exp Neurol; 2016 Nov; 285(Pt A):61-71. PubMed ID: 27637804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
    Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
    Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain.
    Yang W; Wang G; Wang CE; Guo X; Yin P; Gao J; Tu Z; Wang Z; Wu J; Hu X; Li S; Li XJ
    J Neurosci; 2015 May; 35(21):8345-58. PubMed ID: 26019347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model.
    Smith WW; Liu Z; Liang Y; Masuda N; Swing DA; Jenkins NA; Copeland NG; Troncoso JC; Pletnikov M; Dawson TM; Martin LJ; Moran TH; Lee MK; Borchelt DR; Ross CA
    Hum Mol Genet; 2010 Jun; 19(11):2087-98. PubMed ID: 20185556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.
    Mammadova N; Baron T; Verchère J; Greenlee JJ; Greenlee MHW
    Methods Mol Biol; 2021; 2224():75-85. PubMed ID: 33606207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease.
    Kilpeläinen T; Julku UH; Svarcbahs R; Myöhänen TT
    Sci Rep; 2019 Nov; 9(1):17382. PubMed ID: 31758049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.
    Vidal-Martínez G; Vargas-Medrano J; Gil-Tommee C; Medina D; Garza NT; Yang B; Segura-Ulate I; Dominguez SJ; Perez RG
    J Biol Chem; 2016 Sep; 291(39):20811-21. PubMed ID: 27528608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.
    Norris EH; Uryu K; Leight S; Giasson BI; Trojanowski JQ; Lee VM
    Am J Pathol; 2007 Feb; 170(2):658-66. PubMed ID: 17255333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.
    Xie B; Lin F; Ullah K; Peng L; Ding W; Dai R; Qing H; Deng Y
    Biochem Biophys Res Commun; 2015 Apr; 459(3):361-6. PubMed ID: 25744031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
    Kumar S; Sarkar A; Sundar D
    Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage preceding dopamine neuron degeneration in A53T human α-synuclein transgenic mice.
    Wang D; Yu T; Liu Y; Yan J; Guo Y; Jing Y; Yang X; Song Y; Tian Y
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):104-110. PubMed ID: 27818201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
    Deusser J; Schmidt S; Ettle B; Plötz S; Huber S; Müller CP; Masliah E; Winkler J; Kohl Z
    J Neurochem; 2015 Nov; 135(3):589-97. PubMed ID: 26201615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.
    Noorian AR; Rha J; Annerino DM; Bernhard D; Taylor GM; Greene JG
    Neurobiol Dis; 2012 Oct; 48(1):9-19. PubMed ID: 22722052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Parkinson's disease symptoms in α-synuclein transgenic monkeys.
    Niu Y; Guo X; Chen Y; Wang CE; Gao J; Yang W; Kang Y; Si W; Wang H; Yang SH; Li S; Ji W; Li XJ
    Hum Mol Genet; 2015 Apr; 24(8):2308-17. PubMed ID: 25552648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.